Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Victoria, TX MSA — October 2026
Victoria's thin bench collides with a 53% surge in Texas biopharma postings.
Victoria MSA unemployment fell to 4.4% against a 45,000-person labor force, even as statewide biopharma job postings jumped 53% year-over-year and local Regulatory Affairs pay slipped to $95,473 against a national median of $103,780.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Victoria MSA unemployment: 4.4% — Down from 4.6% in August; Texas state rate 4.4%
- Texas biopharma job postings growth: +53% YoY — Jan–Aug 2026, outpacing state hiring capacity
- Metro Regulatory Affairs Specialist pay: $95,473 — vs national $103,780, despite national scarcity
- National biopharma quit rate: 1.9% — Limits attrition-driven hiring in tight metros
Key takeaways
Regulatory Affairs pay drop looks like a pricing gap amid steady demand.
Metro Regulatory Affairs Specialist pay fell to $95,473 even as national postings for the role remain among the hardest to fill in pharma. A nearly $8,300 local-to-national gap may understate true difficulty-to-fill risk and warrants a compensation review before the next search.
Biostatistician pay in Victoria now outpaces the national figure.
Metro Biostatistician median of $139,166 exceeds the national $131,958, an unusual local premium for a market this size. This likely reflects a thin bench of credentialed statisticians, meaning one departure could reset the local pay bar.
Tight metro labor force limits attrition-driven hiring capacity.
A 45,000-person labor force and 4.4% unemployment leave few available workers to absorb new life sciences headcount without poaching from adjacent employers. Build-vs-outsource decisions for clinical operations and CMC work should weight the limited local bench more heavily than state-level job growth figures suggest.
CRA pay gap between Victoria and the national market is widening.
Metro Clinical Research Associate pay sits at $78,893 against a national median of $90,065, a gap approaching $11,200. With experienced CRAs cited nationally as the binding constraint on clinical operations capacity, this spread may force Victoria employers toward remote or hybrid CRA models to compete.
Median advertised pay by role — Victoria, TX MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,765 | $123,070 | $131,979 | Significant increase | $130,339 |
| Clinical Research Associate * | $57,977 | $78,893 | $95,462 | Moderate increase | $90,065 |
| Lab Technician * | $38,082 | $45,670 | $49,588 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $70,793 | $95,473 | $116,373 | Moderate decline | $103,780 |
| Clinical Data Manager * | $96,453 | $122,953 | $135,700 | Stable | $123,653 |
| Biostatistician * | $98,485 | $139,166 | $160,691 | Moderate increase | $131,958 |
| Validation Engineer * | $82,756 | $104,143 | $112,977 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Victoria MSA unemployment eased to 4.4% in September from 4.6% in August, with a labor force of roughly 45,000 that leaves little slack for specialized scientific or regulatory hiring. Statewide biopharma job postings surged 53% year-over-year while Texas added 4,500 life sciences jobs, meaning Victoria employers compete for credentialed talent against better-resourced Houston and Austin markets without a comparable local candidate pipeline.
What it means
Thin local labor supply combined with a national quit rate of 1.9% means Victoria-based biotech, pharma, and device employers cannot count on attrition-driven hiring to fill regulatory, clinical, or quality roles — most movement will require active recruitment or build-vs-outsource tradeoffs with CROs and CDMOs. Metro Regulatory Affairs Specialist pay fell to $95,473, a signal that local pay has decoupled from the national scarcity narrative, suggesting this role may be underpriced locally relative to its difficulty-to-fill status. Consider reviewing Regulatory Affairs and Validation Engineer compensation against national trends before assuming metro softness reflects reduced skill scarcity.
Looking ahead
Worth watching: Texas biopharma postings grew 53% year-over-year through August; watch whether that demand migrates toward smaller MSAs like Victoria or stays concentrated in Houston and Austin talent corridors.
Emerging pressure point: Regulatory Affairs Specialist pay has moved down locally and nationally even as the role remains cited among the hardest to fill in pharma — a disconnect that could correct sharply if even one local employer initiates a competitive search.
Expected: Statewide WARN filings are down 35% year-over-year, reducing the odds of displaced life sciences talent entering the Victoria candidate pool; plan sourcing timelines accordingly.
Potential inflection point: Texas Medical and Health Biological Science employment grew 14.7% statewide; track whether Victoria's modest nonfarm base (around 40,300 jobs) begins capturing a share of that growth or remains a pass-through market for commuting talent.
Sources
- Texas Workforce Commission — Victoria MSA unemployment rate and labor force size
- Texas life sciences labor market research notes — Texas biopharma job postings surged 53% YoY
- Biopharma industry labor market survey — National biopharma quit rate of 1.9%
- Texas Workforce Commission — Texas WARN filings down 35% year-over-year
- Texas life sciences labor market research notes — Texas Medical and Health Biological Science employment grew 14.7%
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.